These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15704357

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
    Johnson AB, Taylor R.
    Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet.
    Faure E, Pallardo LF, Mesa J, Puig-Domingo M, García-Mayor R, Benito P, Ravella R, Artés M, López JS, MIDIA Study Group.
    Diabetes Care; 2002 Oct; 25(10):1896-8. PubMed ID: 12351510
    [No Abstract] [Full Text] [Related]

  • 34. A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
    Kishimoto M, Noda M.
    Cardiovasc Diabetol; 2011 Dec 22; 10():115. PubMed ID: 22189184
    [Abstract] [Full Text] [Related]

  • 35. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
    Rabasa-Lhoret R, Chiasson JL.
    Drugs Aging; 1998 Aug 22; 13(2):131-43. PubMed ID: 9739502
    [Abstract] [Full Text] [Related]

  • 36. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
    Scheen AJ, Lefèbvre PJ.
    Diabetes Care; 2002 Jan 22; 25(1):247-8. PubMed ID: 11772929
    [No Abstract] [Full Text] [Related]

  • 37. Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus.
    Scott AR, Tattersall RB.
    Diabet Med; 1988 Jan 22; 5(1):42-6. PubMed ID: 2964327
    [Abstract] [Full Text] [Related]

  • 38. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
    Carlson RF.
    Am Fam Physician; 2000 Jul 15; 62(2):315, 318. PubMed ID: 10929699
    [No Abstract] [Full Text] [Related]

  • 39. Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.
    Joubert PH, Foukaridis GN, Bopape ML.
    Eur J Clin Pharmacol; 1987 Jul 15; 31(6):723-4. PubMed ID: 3549325
    [Abstract] [Full Text] [Related]

  • 40. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
    Scheen AJ.
    Drugs; 2003 Jul 15; 63(10):933-51. PubMed ID: 12699398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.